Clinical Research Facility

Scottsboro, Alabama

We've found

2 trials

at this facility

Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma

Status: Enrolling, Phase II, III
Updated: 12/31/1969

from

Scottsboro, AL

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Scottsboro, AL

Use our guide to learn which trials are right for you!